133 related articles for article (PubMed ID: 38894658)
1. In vitro activation of the CB
Persson M; Kronstrand R; Evans-Brown M; Green H
Drug Test Anal; 2024 Jun; ():. PubMed ID: 38894658
[TBL] [Abstract][Full Text] [Related]
2. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review.
Ujváry I
Drug Test Anal; 2024 Feb; 16(2):127-161. PubMed ID: 37269160
[TBL] [Abstract][Full Text] [Related]
3. Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance.
Graziano S; Varì MR; Pichini S; Busardo FP; Cassano T; Di Trana A
Curr Neuropharmacol; 2023; 21(12):2424-2430. PubMed ID: 37357519
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.
Janssens LK; Van Uytfanghe K; Williams JB; Hering KW; Iula DM; Stove CP
Arch Toxicol; 2024 May; ():. PubMed ID: 38735004
[TBL] [Abstract][Full Text] [Related]
5. Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples.
Lindbom K; Norman C; Baginski S; Krebs L; Stalberga D; Rautio T; Wu X; Kronstrand R; Gréen H
Drug Test Anal; 2024 May; ():. PubMed ID: 38804224
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).
Russo F; Vandelli MA; Biagini G; Schmid M; Luongo L; Perrone M; Ricciardi F; Maione S; Laganà A; Capriotti AL; Gallo A; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
Sci Rep; 2023 Jul; 13(1):11061. PubMed ID: 37422571
[TBL] [Abstract][Full Text] [Related]
7. Identification of hexahydrocannabinol (HHC), dihydro-iso-tetrahydrocannabinol (dihydro-iso-THC) and hexahydrocannabiphorol (HHCP) in electronic cigarette cartridge products.
Tanaka R; Kikura-Hanajiri R
Forensic Toxicol; 2024 Jan; 42(1):71-81. PubMed ID: 37365398
[TBL] [Abstract][Full Text] [Related]
8. Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC-MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva.
Höfert L; Becker S; Dreßler J; Baumann S
Drug Test Anal; 2024 May; 16(5):489-497. PubMed ID: 37652872
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantification of both isomers of hexahydrocannabinol, (9R)-hexahydrocannabinol and (9S)-hexahydrocannabinol, in three different matrices by mass spectrometry.
Bottinelli C; Baradian P; Poly A; Hoizey G; Chatenay C
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9711. PubMed ID: 38342829
[TBL] [Abstract][Full Text] [Related]
10. Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC).
Nasrallah DJ; Garg NK
ACS Chem Biol; 2023 Sep; 18(9):2023-2029. PubMed ID: 37578929
[TBL] [Abstract][Full Text] [Related]
11. Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H.
Helander A; Johansson M; Villén T; Andersson A
Scand J Clin Lab Invest; 2024 Apr; 84(2):125-132. PubMed ID: 38619215
[TBL] [Abstract][Full Text] [Related]
12. Identification of human hexahydrocannabinol metabolites in urine.
Schirmer W; Auwärter V; Kaudewitz J; Schürch S; Weinmann W
Eur J Mass Spectrom (Chichester); 2023 Oct; 29(5-6):326-337. PubMed ID: 37709263
[TBL] [Abstract][Full Text] [Related]
13. Hexahydrocannabinol (HHC) and Δ
Durydivka O; Palivec P; Gazdarica M; Mackie K; Blahos J; Kuchar M
Sci Rep; 2024 Apr; 14(1):9181. PubMed ID: 38649680
[TBL] [Abstract][Full Text] [Related]
14. Hexahydrocannabinol on the Light Cannabis Market: The Latest "New" Entry.
Casati S; Rota P; Bergamaschi RF; Palmisano E; La Rocca P; Ravelli A; Angeli I; Minoli M; Roda G; Orioli M
Cannabis Cannabinoid Res; 2024 Apr; 9(2):622-628. PubMed ID: 36445181
[No Abstract] [Full Text] [Related]
15. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
[TBL] [Abstract][Full Text] [Related]
16. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
[TBL] [Abstract][Full Text] [Related]
17. Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.
Docampo-Palacios ML; Ramirez GA; Tesfatsion TT; Okhovat A; Pittiglio M; Ray KP; Cruces W
Molecules; 2023 Sep; 28(17):. PubMed ID: 37687263
[TBL] [Abstract][Full Text] [Related]
18. Evidence of 11-Hydroxy-hexahydrocannabinol and 11-Nor-9-carboxy-hexahydrocannabinol as Novel Human Metabolites of Δ
Falck Jørgensen C; Schou Rasmussen B; Linnet K; Thomsen R
Metabolites; 2023 Nov; 13(12):. PubMed ID: 38132851
[TBL] [Abstract][Full Text] [Related]
19. Using In Silico Molecular Docking to Explain Differences in Receptor Binding Behavior of HHC and THCV Isomers: Revealing New Binding Modes.
Haghdoost M; López de Los Santos Y; Brunstetter M; Ferretti ML; Roberts M; Bonn-Miller MO
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794207
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake.
Pettersson-Pablo P; Oxelbark J
Scand J Clin Lab Invest; 2024 Apr; 84(2):109-114. PubMed ID: 38529884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
